No phaseCompleted
The Impact of Qualia Gluthathione+ on Blood Glutathione Levels
- Sponsor
- Qualia Life Sciences (Industry)
- Enrolment
- 56 enrolled
- Conditions
- Effects of Qualia Glutathione+ on Blood Glutathione Levels; Glutathione
- Interventions
- Qualia Glutathione+ version 1; Qualia Glutathione+ version 2; Placebo
- Ages
- adults, older adults
- Registry
- NCT07221955
Full record on ClinicalTrials.gov
From the registry
This is a double-blind, placebo-controlled, parallel-group, triple-armed, study evaluating the effects of two distinct Qualia Glutathione+ formulations on Whole Blood Glutathione levels in the blood of healthy adults aged 45-75 years. Approximately 18 participants will be assigned to one of three study arms: Qualia Glutathione+ version 1, Qualia Glutathione+ version 2, or placebo. Each participant will take two or three capsules of their assigned product once daily in the morning, with or without food, over a 20-day period. The primary outcome is the change in blood glutathione levels, assessed via in lab blood collection at baseline and study completion. Secondary endpoints include questionnaires measuring health-related quality of life, fatigue, and cognitive functioning (PROMIS Global Health-10, PROMIS Short Form v1.0 - Fatigue 10a, PROMIS Cognitive Function - Short Form 8a), evaluation of safety and tolerability, and an Overall Experience Questionnaire (Appendices 1, 4-7). All assessments, including electronic questionnaires, are completed remotely without in-person visits.
Primary outcomes
- Total Glutathione levels from baseline to Day 20
History
Last registry update
Study completion
Primary completion
Started
Registered